Abstract
References
Articles referenced by this article (39)
Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests?
Hepatology, (5):972-974 2003
MED: 12717376
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.
Am J Gastroenterol, (10):2614-2618 2002
MED: 12385448
Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease.
J Hepatol, (2):239-244 2003
MED: 12873821
Sampling variability of liver fibrosis in chronic hepatitis C.
Hepatology, (6):1449-1457 2003
MED: 14647056
Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.
Hepatology, (2):481-492 2003
MED: 12883493
Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.
Clin Chem, (8):1344-1355 2004
MED: 15192028
Role of liver biopsy in management of chronic hepatitis C: a systematic review.
Hepatology, (5 Suppl 1):S161-72 2002
MED: 12407590
Show 10 more references (10 of 39)
Citations & impact
Impact metrics
Citations of article over time
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1586/14737159.5.1.15
Article citations
Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients.
Biomark Res, 12(1):44, 29 Apr 2024
Cited by: 0 articles | PMID: 38679739 | PMCID: PMC11057169
FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis.
J Clin Med, 10(11):2415, 29 May 2021
Cited by: 21 articles | PMID: 34072480 | PMCID: PMC8198930
Review Free full text in Europe PMC
Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH).
Cells, 8(8):E845, 07 Aug 2019
Cited by: 56 articles | PMID: 31394730 | PMCID: PMC6721710
Review Free full text in Europe PMC
Advanced liver fibrosis and care continuum in emergency department patients with chronic hepatitis C.
Am J Emerg Med, 37(2):286-290, 29 Aug 2018
Cited by: 1 article | PMID: 30409463 | PMCID: PMC6348121
MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Cell Biol Int, 42(10):1370-1376, 10 Aug 2018
Cited by: 38 articles | PMID: 29957876
Go to all (31) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
FibroMAX: towards a new universal biomarker of liver disease?
Expert Rev Mol Diagn, 7(5):481-490, 01 Sep 2007
Cited by: 27 articles | PMID: 17892356
Review
Comparison of FibroTest-ActiTest with histopathology in demonstrating fibrosis and necroinflammatory activity in chronic hepatitis B and C.
Indian J Pathol Microbiol, 53(3):470-475, 01 Jul 2010
Cited by: 3 articles | PMID: 20699505
FibroTest-ActiTest as a non-invasive marker of liver fibrosis.
Gastroenterol Clin Biol, 32(6 suppl 1):22-39, 01 Sep 2008
Cited by: 62 articles | PMID: 18973844
Fibrotest-Actitest: the biochemical marker of liver fibrosis--the Israeli experience.
Isr Med Assoc J, 9(8):588-591, 01 Aug 2007
Cited by: 7 articles | PMID: 17877064